The A-share aviation and airport sector fluctuated higher, with China Eastern Airlines rising more than 8%, China Express Airlines rising nearly 6%, and other stocks such as Air China, China Southern Airlines, Juneyao Airlines, and Shanghai Airport f

International 1. Goldman Sachs: Western capital flows dominate January precious metals market; gold forecasts upside risks. 2. Danske Bank: Short-term risk for the US dollar is skewed upwards after Warsh's nomination. 3. RHB Retail Research: Unless gold closes above $5090/oz, the technical outlook remains bearish. 4. ING: Market expectations for interest rate hikes are excessive; the Australian dollar faces downside risks. 5. Amundi: The ECB may open the door to interest rate cuts this year; low inflation will force further intervention. Domestic 1. CICC: It will be difficult for any Fed chairman to shake the normalization of balance sheet expansion. 2. CITIC Securities: A reserve requirement ratio cut is highly probable in Q2 2026. 3. CITIC Securities: Tight supply and demand + upstream transmission; rising prices for electronic components continue to spread. 4. CITIC Securities: OpenAI is being implemented in advertising monetization; large-scale model commercialization is accelerating. 5. CITIC Securities: Solid-state battery pilot line bidding is imminent; bullish on the spring market for lithium battery equipment. 6. CITIC Securities: Global commercial aerospace enters a new phase centered on large-scale deployment and ecosystem building. 7. Galaxy Securities: The extended holiday provides a boost; platforms and duty-free sectors will reap the rewards. 8. Tianfeng Securities: This year's "Spring Festival rally" may be more sustained. 9. Huatai Securities: The VAT adjustment by the three major telecom operators may have a lower impact on profits than directly estimated. 10. Huatai Securities: Bullish on investment opportunities in "three-good" real estate companies, excellent commercial operators, Hong Kong-funded real estate companies, and high-dividend property management companies.

Novo Nordisk (NVO.N) CEO: Hopefully, an agreement with the Trump administration will be reached to launch health insurance coverage for obesity drugs around the middle of this year.